CTRI/2023/04/051973已完成4 期
A Prospective, Multi-centre, Single-arm, Phase IV Study to Assess the Safety and Efficacy of Amantadine Extended Release Tablets for the Treatment of Parkinsons Disease and Drug-induced Extrapyramidal Reactions in Adult Patients
Sun Pharma Laboratories Limited (SPLL)0 个研究点目标入组 163 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 163
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of either gender aged between 30 to 85 years both inclusive who agree to provide written informed consent
- •Patients who can be managed on outpatient basis as per the Investigators judgment
- •The patient or caregiver must demonstrate the ability to complete an accurate home diary based on training and evaluation during the screening period
- •Women of childbearing potential must have a negative urine pregnancy test before study entry and agree to use highly effective methods of contraception to prevent pregnancy from study entry till at least two weeks after the last dose of the study medication such contraception may include hormonal birth control eg combined estrogen and progestogen containing oral intravaginal or transdermal or progesterone only oral injectable or implantable hormonal contraception associated with inhibition of ovulation intrauterine devices intrauterine hormone releasing system OR bilateral tubal occlusion vasectomized partner or total sexual abstinence
- •Note Women with childbearing potential are defined as those who are not surgically sterile bilateral oophorectomy hysterectomy or bilateral tubal ligation or post menopausal Post menopausal woman will be defined as Woman not using hormonal replacement therapy and have had at least twelve continuous months of natural spontaneous amenorrhea and be greater than forty five years of age
- •Male patients must have had a successful vasectomy confirmed azoospermia or they and their female partners must meet the criteria above ie not of childbearing potential or practicing highly effective contraception throughout the study period No sperm donation is allowed during the study period
- •Patients with diagnosis of idiopathic Parkinsons disease as per the United Kingdom UK Parkinsons Disease Society Brain Bank criteria
- •Patients who are on stable dose of anti parkinsonian medications and require additional medications to control PD symptoms Patients should be on stable dose of any anti parkinsonian medications including any levodopa preparation for at least thirty days prior to enrolment and be willing to remain on the same doses throughout the trial
- •Patients on stable dose of medications before screening such as typical and atypical antipsychotics antidepressants eg SSRIs SNRIs antiemetics eg metoclopramide domperidone levosulpiride or antiepileptic drugs eg valproate phenytoin and experiencing extrapyramidal symptoms such as parkinsonism and or akathisia and or dystonia and or tardive dyskinesia
排除标准
- •Patients having secondary parkinsonian syndrome such as vascular post inflammatory drug induced neoplastic and post traumatic parkinsonism or any atypical parkinsonian syndrome bipolar disorder untreated inadequately treated major depressive disorder Patients on stable dose of selective serotonin reuptake inhibitors or serotonin and norepinephrine reuptake inhibitors for last two months prior to enrolment are eligible schizophrenia or other psychotic disorder history of exposure to a known neurotoxin or any neurological features not consistent with the diagnosis of PD as assessed by the Investigator
- •History of neurosurgical intervention for treating Parkinsons disease ie pallidotomy or implanted with a deep brain stimulator
- •Patients taking any medication for the treatment of extrapyramidal reactions within thirty days prior to Screening
- •Patients with any of the underlying conditions that may cause extrapyramidal symptoms including but not limited to dementia hydrocephalus subdural haemorrhage hypoparathyroidism neurodegeneration and pantothenate kinase associated neurodegeneration
- •Patients taking amantadine within thirty days prior to screening
- •Patients with previously documented inability to tolerate amantadine or lack of response to prior amantadine treatment
- •Patients taking rimantadine for influenza prophylaxis or any other indication memantine or apomorphine within thirty days prior to screening
- •History of any cancer within five years of screening
- •Patients who are at imminent risk of suicide or had a suicide attempt within last one year of screening
- •Patients who have received Live Attenuated Influenza Vaccine within two weeks prior to Screening
- •Patients who have plans to undergo major elective surgery during the course of the study
- •Patients with end stage renal disease eGFR less than 15 mL/min/1.73 m2 calculated by MDRD method at the time of screening and enrolment
- •History of or currently has any of the following clinically significant conditions such as cardiovascular respiratory renal hepatic endocrine or gastrointestinal disease
- •History or known case of HIV-AIDS hepatitis B and hepatitis C
- •History of hypersensitivity or allergic reaction to amantadine rimantadine or memantine or to any of the excipients used in the study medication
- •Participation in other studies involving investigational drugs or surgeries within the last thirty days or investigational biologics within the last 6 months prior to screening
- •Pregnant or lactating women
- •Investigator study personnel Sponsor representatives and their first degree relatives
研究者
相似试验
尚未招募
4 期
Safety and efficacy of Brinzolamide and Timolol eye drops to decrease intraocular pressure in adult patients with open-angle glaucoma or ocular hypertension for whom single drug therapy provides insufficient for intraocular pressure reductioCTRI/2023/05/052720Sun Pharma Laboratories Limited (SPLL)
已完成
4 期
Safety and Efficacy of Cariprazine Capsules in Adult Patients with Schizophrenia (a disorder that affects a persons ability to think, feel and behave clearly) and Acute Treatment of Manic or Mixed Episodes Associated with Bipolar I Disorder (mood swings that include emotional highs and lows)CTRI/2023/05/052793Sun Pharmaceutical Industries Limited172
尚未招募
4 期
Effects of Amoxycillin and Potassium Clavulanate Oral Syrup in Children With Respiratory InfectioCTRI/2023/08/056267Sun Pharmaceuticals Industries Limited SPI
尚未招募
4 期
A study of Fixed Dose Combination of Tamsulosin and Tadalafil Capsules to check safety and efficacy in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction.CTRI/2022/06/043152Sun Pharma Laboratory Limited SP
已完成
4 期
A clinical study to assess the efficacy and safety of Glycopyrrolate, Formoterol Fumarate and Budesonide Inhalation in patients with Chronic Obstructive Pulmonary DiseaseCTRI/2023/03/050717Zydus Healthcare Limited200